Back to Search Results
Image Place holder

Bela Kis, MD, PhD

 
Specialty: Interventional Radiology
Program: Diagnostic Imaging and Interventional Radiology

Call 1-888-663-3488

Call 1-888-663-3488


Locations:
Overview

Cancer Focus: Cholangiocarcinoma (Bile Duct Cancer), Colon Cancer, Colorectal Cancer, Gastrointestinal Carcinoid Tumor, GIST (Gastrointestinal Stromal Tumor), Kidney (Renal Cell) Cancer, Liver Cancer, Mesothelioma, Neuroendocrine Tumor, Pancreatic Cancer, Sarcoma

Dr. Bela Kis is an Associate Member in the Diagnostic Imaging & Interventional Radiology Program at Moffitt Cancer Center, an Associate Professor of Oncologic Sciences at the University of South Florida and a Fellow of the Society of Interventional Radiology (FSIR). He is the Co-Section Head of Interventional Radiology responsible for Clinical Operations and Research. Dr. Kis earned his MD and PhD from the University of Szeged in Hungary. He completed a Radiology Residency at Brigham and Women’s Hospital, Harvard Medical School, where he also served as Chief Resident. He then completed an Interventional Radiology Fellowship at Brigham and Women’s Hospital, Harvard Medical School. Dr. Kis’ clinical interests include image-guided tumor therapy including transcatheter chemo- and radio-embolizations, minimally invasive percutaneous tumor ablation (NanoKnife, cryo- and radiofrequency ablation), image-guided biopsies, image-guided urinary and biliary interventions, arterial and venous stenting, uterine fibroid embolization, pelvic congestion syndrome, vertebroplasty and kyphoplasty. Dr. Kis recently introduced thyroid radiofrequency ablation (RFA) at Moffitt Cancer Center, which is one of the very few programs in the US. His research encompasses new techniques in minimally invasive, image-guided tumor therapy with focus on chemoperfusion treatment of mesothelioma, irreversible electroporation (Nanoknife) treatment of unresectable pancreatic cancer, radioembolization treatment for primary and metastatic liver tumors and partial splenic embolization to increase platelet count in patients with thrombocytopenia.


Education & Training

Fellowship:

  • Brigham and Women's Hospital, Harvard Medical School - Interventional Radiology
  • Wake Forest University Baptist Medical Center - Physiology and Pharmacology
  • University of Occupational and Environmental Health, School of Medicine, Japan - Physiology

Residency:

  • Brigham and Women's Hospital, Harvard Medical School - Radiology

Medical School:

  • University of Szeged, Hungary - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Kis B, Shridhar R, Mhaskar R, Gyano M, Frakes JM, El-Haddad G, Choi J, Kim RD, Hoffe SE. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma - A Prospective Feasibility Study. J Vasc Interv Radiol. 2023 May. Pubmedid: 37210030.
  • Poovathukaran Babu A, Kis B, Patrick J, Verma N. Partial Splenic Artery Embolization in the Management of Acute Immune Thrombocytopenia Refractory to Medical Treatment. Ann Intern Med Clin Cases. 2023 Mar.
  • Bibok A, Kis B, Frakes J, Hoffe S, Zhang J, Jain R, Parikh N. Yttrium-90 Radioembolization for Liver-Dominant Metastatic Prostate Cancer: A Case Series. J Vasc Interv Radiol. 2022 Sep.33(9):1061-1065. Pubmedid: 36049841.
  • Kumar P, Mhaskar R, Kim R, Anaya D, Frakes J, Hoffe S, Choi J, Kis B. Unresectable Intrahepatic Cholangiocarcinoma Treated with Radiation Segmentectomy/Lobectomy Using Yttrium 90-labeled Glass Microspheres. J Clin Exp Hepatol. 2022 Sep.12(5):1259-1263. Pubmedid: 36157145. Pmcid: PMC9499841.
  • Johnson W, Weekley A, Suz P, Parikh N, El-Haddad G, Mhaskar R, Kis B. Safety of CT-Guided Microwave Ablation of Subcardiac Liver Tumors. Cardiovasc Intervent Radiol. 2022 Nov.45(11):1693-1700. Pubmedid: 35941243.
  • Robinson LA, Fontaine J, El-Haddad G, Bryant S, Perez B, Toloza E, Kis B. Novel Subdiaphragmatic Ligation of Left Thoracic Duct for Refractory Postoperative Left Chylothorax. Ann Thorac Surg. 2022 Jan.113(1):e29-e31. Pubmedid: 33794166.
  • Ehab J, Powers B, Kim R, Haider M, Utuama O, Chin A, Denbo J, Kis B, Frakes J, Jeong D, Lauwers G, Vadaparampil S, Fleming JB, Anaya DA. Integrating a Disease-Focused Tumor Board as a Delivery-of-Care Model to Expedite Treatment Initiation for Patients With Liver Malignancies. Ann Surg Oncol. 2022 Apr.29(4):2371-2380. Pubmedid: 34671878.
  • Ehab J, Powers B, Kim R, Haider M, Utuama O, Chin A, Denbo J, Kis B, Frakes J, Jeong D, Lauwers G, Vadaparampil S, Fleming JB, Anaya DA. ASO Visual Abstract: Integrating a Disease-Focused Tumor Board as a Delivery-of-Care Model to Expedite Treatment Initiation for Patients with Liver Malignancies. Ann Surg Oncol. 2022 Apr.29(4):2381-2382. Pubmedid: 34716839.
  • Halwani AS, Panizo C, Isufi I, Herrera AF, Okada CY, Cull EH, Kis B, Chaves JM, Bartlett NL, Ai W, de la Cruz-Merino L, Bryan LJ, Houot R, Linton K, Briones J, Chau I, von Keudell GR, Lu H, Yakovich A, Chen M, Meulen JHT, Yurasov S, Hsu FJ, Flowers CR. Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma. Leuk Lymphoma. 2022 Apr.63(4):821-833. Pubmedid: 34865586.
  • Barakat E, Bibok A, Rishi A, Ahmed A, Frakes JM, Hoffe SE, Armaghani AJ, Soyano AE, Costa RLB, El-Haddad G, Choi J, Kis B. Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study. Adv Radiat Oncol. 2021 Oct.7(1):100838. Pubmedid: 35071835. Pmcid: PMC8767250.
  • Bibok A, Mhaskar R, Jain R, Zhang J, Frakes J, Hoffe S, El-Haddad G, Parikh N, Ahmed A, Fishman MN, Choi J, Kis B. Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study. Cardiovasc Intervent Radiol. 2021 Nov.44(11):1755-1762. Pubmedid: 34312688.
  • Bibok A, Kim DW, Malafa M, Kis B. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. World J Gastroenterol. 2021 Jul.27(27):4322-4341. Pubmedid: 34366607. Pmcid: PMC8316906.
  • Afiat TP, Johns C, Smith J, Kis B, Druta M. Adrenal crisis and death following transarterial chemoembolization of sarcoma liver metastases. Clin Imaging. 2021 Jan.69:79-81. Pubmedid: 32693227.
  • Krzyston H, Morse B, Deperalta D, Rishi A, Kayaleh R, El-Haddad G, Smith J, Druta M, Kis B. Liver-directed treatments of liver-dominant metastatic leiomyosarcoma. Diagn Interv Radiol. 2020 Sep.26(5):449-455. Pubmedid: 32673206. Pmcid: PMC7490031.
  • Makovich Z, Logemann J, Chen L, Mhaskar R, Choi J, Parikh N, El-Haddad G, Kis B. Liver tumor ablation in difficult locations: Microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma. Clin Imaging. 2020 Nov.71:170-177. Pubmedid: 33285405.
  • Pointer DT, Durgan DM, Kis B, Khakpour N, Kiluk JV. High-output chyle leak after breast-conserving surgery and sentinel lymph node biopsy. Breast J. 2020 Mar.26(3):514-516. Pubmedid: 31495018.
  • Kis LE, Centeno BA, Anaya DA, Kis B. Hepatic adenoma rupture following portal vein embolization. Radiol Case Rep. 2020 Jun.15(6):664-667. Pubmedid: 32280397. Pmcid: PMC7136602.
  • Kayaleh R, Krzyston H, Rishi A, Naziri J, Frakes J, Choi J, El-Haddad G, Parikh N, Sweeney J, Kis B. Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study. J Vasc Interv Radiol. 2020 Jul.31(7):1060-1068. Pubmedid: 32534978.
  • Kis B, Kayaleh R. Transsplenic Microwave Ablation of Pancreatic Adenocarcinoma in a Morbidly Obese Patient. J Vasc Interv Radiol. 2020 Jul.31(7):1168-1169. Pubmedid: 32564895.
  • Iyer RV, Acquisto SG, Bridgewater JA, Choti MA, Hong TS, Kis B, Mead PA, Parikh ND, Roberts LR, Roberts R, Salem R, Sicklick JK, Siegel RS, Whisenant JR, Cherepanov D, Broder MS, Valle JW. Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters using the Modified RAND/UCLA Delphi Process. Cancers (Basel). 2020 Aug.12(9). Pubmedid: 32825784. Pmcid: PMC7565442.
  • Kis B, Mills M, Smith J, Choi J, Sagatys E, Komrokji R, Strosberg J, Kim RD. Partial Splenic Artery Embolization in 35 Cancer Patients: Results of a Single Institution Retrospective Study. J Vasc Interv Radiol. 2020 Apr.31(4):584-591. Pubmedid: 31471193.
  • Sweeney J, Parikh N, El-Haddad G, Kis B. Ablation of Intrahepatic Cholangiocarcinoma. Semin Intervent Radiol. 2019 Oct.36(4):298-302. Pubmedid: 31680720. Pmcid: PMC6823041.
  • Sweeney J, Biebel B, Kis B. Complication of hemothorax after CT-guided percutaneous biopsy of herniated liver masquerading as a pulmonary mass. Radiol Case Rep. 2019 Jan.14(1):129-132. Pubmedid: 30377457. Pmcid: PMC6204432.
  • Mohammadi H, Abuodeh Y, Jin W, Frakes J, Friedman M, Biebel B, Choi J, El-Haddad G, Kis B, Sweeney J, Hoffe S. Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma. J Gastrointest Oncol. 2018 Oct.9(5):840-846. Pubmedid: 30505583. Pmcid: PMC6219966.
  • Orcutt ST, Abuodeh Y, Naghavi A, Frakes J, Hoffe S, Kis B, Anaya DA. Kinetic analysis of contralateral liver hypertrophy after radioembolization of primary and metastatic liver tumors. Surgery. 2018 May.163(5):1020-1027. Pubmedid: 29325784.
  • Frakes JM, Abuodeh YA, Naghavi AO, Echevarria MI, Shridhar R, Friedman M, Kim R, El-Haddad G, Kis B, Biebel B, Sweeney J, Choi J, Anaya D, Giuliano AR, Hoffe SE. Viral hepatitis associated hepatocellular carcinoma outcomes with yttrium-90 radioembolization. J Gastrointest Oncol. 2018 Jun.9(3):546-552. Pubmedid: 29998020. Pmcid: PMC6006034.
  • Gangi A, Shah J, Hatfield N, Smith J, Sweeney J, Choi J, El-Haddad G, Biebel B, Parikh N, Arslan B, Hoffe SE, Frakes JM, Springett GM, Anaya DA, Malafa M, Chen DT, Chen Y, Kim RD, Shridhar R, Kis B. Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study. J Vasc Interv Radiol. 2018 Aug.29(8):1101-1108. Pubmedid: 30042074. Pmcid: PMC7771272.
  • Orcutt S, Kis B, Malafa M. Case report: Irreversible electroporation for locally advanced pancreatic cancer. Int J Surg Case Rep. 2017 Sep.40:54-57. Pubmedid: 28941969. Pmcid: PMC5609870.
  • Kis B, El-Haddad G, Sheth RA, Parikh NS, Ganguli S, Shyn PB, Choi J, Brown KT. Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control. 2017 Jul.24(3). Pubmedid: 28975829. Pmcid: PMC5937250.
  • Nanjappa S, Pla-Fernandez CA, Apuri S, Loftus L, Kis B. Liver-Directed Embolization for the Long-Term Control of Hypercalcemia of Malignancy in Metastatic Breast Cancer. Cancer Control. 2017 Jan.24(1):57-59. Pubmedid: 28178714.
  • Kis B, Shah J, Choi J, El-Haddad G, Sweeney J, Biebel B, Mellon E, Frakes JM, Hoffe SE, Fishman MN, Shridhar R. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma. J Vasc Interv Radiol. 2017 Feb.28(2):254-259. Pubmedid: 27955832. Pmcid: PMC7771309.
  • Mills M, Choi J, El-Haddad G, Sweeney J, Biebel B, Robinson L, Antonia S, Kumar A, Kis B. Retrospective analysis of technical success rate and procedure-related complications of 867 percutaneous CT-guided needle biopsies of lung lesions. Clin Radiol. 2017 Dec.72(12):1038-1046. Pubmedid: 28851490.
  • Kis B, Mills M, Hoffe SE. Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access. Diagn Interv Radiol. 2016 Sep.22(5):444-449. Pubmedid: 27353460. Pmcid: PMC5019848.
  • Hill ED, Nanjappa S, Kis B. Klebsiella pneumoniae Hepatic Abscess and Bacteremia Despite Prophylactic Antibiotics Posttransarterial Bland Embolization. Infect Dis Clin Prac. 2016 Sep.24(5):e24-e26.
  • Mohammadi H, Abuodeh YA, Jin W, Frakes JM, Friedman M, Biebel B, Choi J, El-Haddad GE, Kis B, Sweeney J, Kim R, Pimiento JM, Malafa MP, Anaya D, Hoffe SE. Using the ALBI Grade as a Prognostic Marker for Radioembolization of Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2016 Oct.96(2S):E194-E195.
  • Abuodeh Y, Naghavi AO, Ahmed KA, Venkat PS, Kim Y, Kis B, Choi J, Biebel B, Sweeney J, Anaya DA, Kim R, Malafa M, Frakes JM, Hoffe SE, El-Haddad G. Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization. World J Gastroenterol. 2016 Dec.22(47):10406-10414. Pubmedid: 28058021. Pmcid: PMC5175253.
  • Abbott AM, Kim R, Hoffe SE, Arslan B, Biebel B, Choi J, El-Haddad G, Kis B, Sweeney J, Meredith KL, Almhanna K, Strosberg J, Shibata D, Fulp WJ, Shridhar R. Outcomes of Therasphere Radioembolization for Colorectal Metastases. Clin Colorectal Cancer. 2015 Sep.14(3):146-153. Pubmedid: 25795047.
  • Kis B, Pamarthi V, Fan CM, Rabkin D, Baum RA. Safety and utility of transjugular liver biopsy in hematopoietic stem cell transplant recipients. J Vasc Interv Radiol. 2013 Jan.24(1):85-89. Pubmedid: 23200125.
  • Varban OA, Ardestani A, Azagury DE, Kis B, Brooks DC, Tavakkoli A. Contemporary management of adult intussusception: who needs a resection?. World J Surg. 2013 Aug.37(8):1872-1877. Pubmedid: 23571865.
  • Kis B, O'Regan KN, Agoston A, Javery O, Jagannathan J, Ramaiya NH. Imaging of desmoplastic small round cell tumour in adults. Br J Radiol. 2012 Feb.85(1010):187-192. Pubmedid: 22128126.
  • Javery O, Krajewski K, O'Regan K, Kis B, Giardino A, Jagannathan J, Ramaiya NH. A to Z of extraskeletal Ewing sarcoma family of tumors in adults: imaging features of primary disease, metastatic patterns, and treatment responses. Ajr Am J Roentgenol. 2011 Dec.197(6):W1015-W1022. Pubmedid: 22109315.
  • Domoki F, Kis B, Gáspár T, Snipes JA, Bari F, Busija DW. Rosuvastatin induces delayed preconditioning against L-glutamate excitotoxicity in cultured cortical neurons. Neurochem Int. 2010 Feb.56(3):404-409. Pubmedid: 19931334. Pmcid: PMC2824032.
  • Domoki F, Kis B, Gáspár T, Snipes JA, Parks JS, Bari F, Busija DW. Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. Am J Physiol Cell Physiol. 2009 Jan.296(1):C97-105. Pubmedid: 18971391. Pmcid: PMC2636993.
  • Domoki F, Kis B, Gáspár T, Bari F, Busija DW. Cerebromicrovascular endothelial cells are resistant to L-glutamate. Am J Physiol Regul Integr Comp Physiol. 2008 Oct.295(4):R1099-R1108. Pubmedid: 18667711. Pmcid: PMC2576095.
  • Csányi G, Kis B, Gecse A, Telegdy G, Szupera Z, Vécsei L, Szente M, Leprán I, Mezei Z. Effects of 3-aminopyridine-induced seizures on platelet eicosanoid synthesis. Pharmacol Rep. 2008 May.60(3):345-352. Pubmedid: 18622059.
  • Gáspár T, Katakam P, Snipes JA, Kis B, Domoki F, Bari F, Busija DW. Delayed neuronal preconditioning by NS1619 is independent of calcium activated potassium channels. J Neurochem. 2008 May.105(4):1115-1128. Pubmedid: 18182041. Pmcid: PMC2814534.
  • Gáspár T, Snipes JA, Busija AR, Kis B, Domoki F, Bari F, Busija DW. ROS-independent preconditioning in neurons via activation of mitoK(ATP) channels by BMS-191095. J Cereb Blood Flow Metab. 2008 Jun.28(6):1090-1103. Pubmedid: 18212794.
  • Lenzsér G, Kis B, Snipes JA, Gáspár T, Sándor P, Komjáti K, Szabó C, Busija DW. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. J Cereb Blood Flow Metab. 2007 Jul.27(7):1318-1326. Pubmedid: 17213862.
  • Hortobágyi L, Kis B, Hrabák A, Horváth B, Huszty G, Schweer H, Benyó B, Sándor P, Busija DW, Benyó Z. Adaptation of the hypothalamic blood flow to chronic nitric oxide deficiency is independent of vasodilator prostanoids. Brain Res. 2007 Feb.1131(1):129-137. Pubmedid: 17161389. Pmcid: PMC1820619.
  • Mayanagi K, Gáspár T, Katakam PV, Kis B, Busija DW. The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2007 Feb.27(2):348-355. Pubmedid: 16736040.
  • Gáspár T, Kis B, Snipes JA, Lenzsér G, Mayanagi K, Bari F, Busija DW. Neuronal preconditioning with the antianginal drug, bepridil. J Neurochem. 2007 Aug.102(3):595-608. Pubmedid: 17394552.
  • Chen L, Kis B, Hashimoto H, Busija DW, Takei Y, Yamashita H, Ueta Y. Adrenomedullin 2 protects rat cerebral endothelial cells from oxidative damage in vitro. Brain Res. 2006 May.1086(1):42-49. Pubmedid: 16616051.
  • Horiguchi T, Snipes JA, Kis B, Shimizu K, Busija DW. Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. Neuroscience. 2006 Jun.140(2):723-730. Pubmedid: 16567054.
  • Kis B, Snipes JA, Gaspar T, Lenzser G, Tulbert CD, Busija DW. Cloning of cyclooxygenase-1b (putative COX-3) in mouse. Inflamm Res. 2006 Jul.55(7):274-278. Pubmedid: 16955389.
  • Gáspár T, Kis B, Snipes JA, Lenzsér G, Mayanagi K, Bari F, Busija DW. Transient glucose and amino acid deprivation induces delayed preconditioning in cultured rat cortical neurons. J Neurochem. 2006 Jul.98(2):555-565. Pubmedid: 16805846.
  • Kis B, Chen L, Ueta Y, Busija DW. Autocrine peptide mediators of cerebral endothelial cells and their role in the regulation of blood-brain barrier. Peptides. 2006 Jan.27(1):211-222. Pubmedid: 16137789.
  • Kobayashi H, Yokoo H, Yanagita T, Satoh S, Kis B, Deli M, Niwa M, Wada A. Induction of aquaporin 1 by dexamethasone in lipid rafts in immortalized brain microvascular endothelial cells. Brain Res. 2006 Dec.1123(1):12-19. Pubmedid: 17074307.
  • Kis B, Isse T, Snipes JA, Chen L, Yamashita H, Ueta Y, Busija DW. Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood-brain and blood-cerebrospinal fluid barriers. J Appl Physiol Respir Environ Exerc Physiol. 2006 Apr.100(4):1392-1399. Pubmedid: 16322371.
  • Kis B, Snipes JA, Busija DW. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther. 2005 Oct.315(1):1-7. Pubmedid: 15879007.
  • Horiguchi T, Kis B, Rajapakse N, Shimizu K, Busija DW. Cortical spreading depression (CSD)-induced tolerance to transient focal cerebral ischemia in halothane anesthetized rats is affected by anesthetic level but not ATP-sensitive potassium channels. Brain Res. 2005 Nov.1062(1-2):127-133. Pubmedid: 16256083.
  • Snipes JA, Kis B, Shelness GS, Hewett JA, Busija DW. Cloning and characterization of cyclooxygenase-1b (putative cyclooxygenase-3) in rat. J Pharmacol Exp Ther. 2005 May.313(2):668-676. Pubmedid: 15650114.
  • Horiguchi T, Snipes JA, Kis B, Shimizu K, Busija DW. The role of nitric oxide in the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. Brain Res. 2005 Mar.1039(1-2):84-89. Pubmedid: 15781049.
  • Lenzsér G, Kis B, Bari F, Busija DW. Diazoxide preconditioning attenuates global cerebral ischemia-induced blood-brain barrier permeability. Brain Res. 2005 Jul.1051(1-2):72-80. Pubmedid: 16004973.
  • Busija DW, Katakam P, Rajapakse NC, Kis B, Grover G, Domoki F, Bari F. Effects of ATP-sensitive potassium channel activators diazoxide and BMS-191095 on membrane potential and reactive oxygen species production in isolated piglet mitochondria. Brain Res Bull. 2005 Jul.66(2):85-90. Pubmedid: 15982523.
  • Domoki F, Kis B, Nagy K, Farkas E, Busija DW, Bari F. Diazoxide preserves hypercapnia-induced arteriolar vasodilation after global cerebral ischemia in piglets. Am J Physiol Heart Circ Physiol. 2005 Jul.289(1):H368-H373. Pubmedid: 15734886.
  • Chen L, Kis B, Busija DW, Yamashita H, Ueta Y. Adrenomedullin protects rat cerebral endothelial cells from oxidant damage in vitro. Regul Pept. 2005 Aug.130(1-2):27-34. Pubmedid: 15913808.
  • Kis B, Snipes JA, Simandle SA, Busija DW. Acetaminophen-sensitive prostaglandin production in rat cerebral endothelial cells. Am J Physiol Regul Integr Comp Physiol. 2005 Apr.288(4):R897-R902. Pubmedid: 15618346.
  • Busija DW, Lacza Z, Rajapakse N, Shimizu K, Kis B, Bari F, Domoki F, Horiguchi T. Targeting mitochondrial ATP-sensitive potassium channels--a novel approach to neuroprotection. Brain Res Brain Res Rev. 2004 Nov.46(3):282-294. Pubmedid: 15571770.
  • Nagy K, Kis B, Rajapakse NC, Bari F, Busija DW. Diazoxide preconditioning protects against neuronal cell death by attenuation of oxidative stress upon glutamate stimulation. J Neurosci Res. 2004 Jun.76(5):697-704. Pubmedid: 15139028.
  • Kis B, Snipes A, Bari F, Busija DW. Regional distribution of cyclooxygenase-3 mRNA in the rat central nervous system. Brain Res Mol Brain Res. 2004 Jul.126(1):78-80. Pubmedid: 15207919.
  • Kis B, Nagy K, Snipes JA, Rajapakse NC, Horiguchi T, Grover GJ, Busija DW. The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioning. Neuroreport. 2004 Feb.15(2):345-349. Pubmedid: 15076766.
  • Erdös B, Snipes JA, Kis B, Miller AW, Busija DW. Vasoconstrictor mechanisms in the cerebral circulation are unaffected by insulin resistance. Am J Physiol Regul Integr Comp Physiol. 2004 Dec.287(6):R1456-R1461. Pubmedid: 15331381.
  • Chen L, Hashida S, Kitamura K, Eto T, Kangawa K, Serino R, Kis B, Yamashita H, Ueta Y. Disassociated increases of adrenomedullin in the rat cerebrospinal fluid and plasma after salt loading and systemic administration of lipopolysaccharide. Peptides. 2004 Apr.25(4):609-614. Pubmedid: 15165716.
  • Kis B, Rajapakse NC, Snipes JA, Nagy K, Horiguchi T, Busija DW. Diazoxide induces delayed pre-conditioning in cultured rat cortical neurons. J Neurochem. 2003 Nov.87(4):969-980. Pubmedid: 14622127.
  • Kis B, Snipes JA, Isse T, Nagy K, Busija DW. Putative cyclooxygenase-3 expression in rat brain cells. J Cereb Blood Flow Metab. 2003 Nov.23(11):1287-1292. Pubmedid: 14600435.
  • Rajapakse N, Kis B, Horiguchi T, Snipes J, Busija D. Diazoxide pretreatment induces delayed preconditioning in astrocytes against oxygen glucose deprivation and hydrogen peroxide-induced toxicity. J Neurosci Res. 2003 Jul.73(2):206-214. Pubmedid: 12836163.
  • Kis B, Abrahám CS, Deli MA, Kobayashi H, Niwa M, Yamashita H, Busija DW, Ueta Y. Adrenomedullin, an autocrine mediator of blood-brain barrier function. Hypertens Res. 2003 Feb.26 Suppl:S61-S70. Pubmedid: 12630813.
  • Lacza Z, Snipes JA, Kis B, Szabó C, Grover G, Busija DW. Investigation of the subunit composition and the pharmacology of the mitochondrial ATP-dependent K+ channel in the brain. Brain Res. 2003 Dec.994(1):27-36. Pubmedid: 14642445.
  • Horiguchi T, Kis B, Rajapakse N, Shimizu K, Busija DW. Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke. 2003 Apr.34(4):1015-1020. Pubmedid: 12649508.
  • Kis B, Snipes JA, Deli MA, Abrahám CS, Yamashita H, Ueta Y, Busija DW. Chronic adrenomedullin treatment improves blood-brain barrier function but has no effects on expression of tight junction proteins. Acta Neurochir Suppl. 2003.86:565-568. Pubmedid: 14753507.
  • Rajapakse N, Shimizu K, Kis B, Snipes J, Lacza Z, Busija D. Activation of mitochondrial ATP-sensitive potassium channels prevents neuronal cell death after ischemia in neonatal rats. Neurosci Lett. 2002 Jul.327(3):208-212. Pubmedid: 12113913.
  • Lacza Z, Puskar M, Kis B, Perciaccante JV, Miller AW, Busija DW. Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am J Physiol Heart Circ Physiol. 2002 Jul.283(1):H406-H411. Pubmedid: 12063315.
  • Kis B, Kaiya H, Nishi R, Deli MA, Abrahám CS, Yanagita T, Isse T, Gotoh S, Kobayashi H, Wada A, Niwa M, Kangawa K, Greenwood J, Yamashita H, Ueta Y. Cerebral endothelial cells are a major source of adrenomedullin. J Neuroendocrinol. 2002 Apr.14(4):283-293. Pubmedid: 11963825.
  • Kis B, Abrahám CS, Deli MA, Kobayashi H, Wada A, Niwa M, Yamashita H, Ueta Y. Adrenomedullin in the cerebral circulation. Peptides. 2001 Nov.22(11):1825-1834. Pubmedid: 11754969.
  • Kis B, Deli MA, Kobayashi H, Abrahám CS, Yanagita T, Kaiya H, Isse T, Nishi R, Gotoh S, Kangawa K, Wada A, Greenwood J, Niwa M, Yamashita H, Ueta Y. Adrenomedullin regulates blood-brain barrier functions in vitro. Neuroreport. 2001 Dec.12(18):4139-4142. Pubmedid: 11742253.
  • Kis B, Mezei Z, Forgács P, Gecse A, Telegdy G, Bari F. Prostanoid synthesis in the cerebral blood vessels of asphyxiated piglets. Acta Physiol Hung. 2001.88(2):87-100. Pubmedid: 11999809.
  • Mezei Z, Kis B, Gecse A, Tajti J, Boda B, Telegdy G, Vécsei L. Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets. 2000 Jun.11(4):222-225. Pubmedid: 10938901.
  • Szupera Z, Mezei Z, Kis B, Gecse A, Vécsei L, Telegdy G. The effects of valproate on the arachidonic acid metabolism of rat brain microvessels and of platelets. Eur J Pharmacol. 2000 Jan.387(2):205-210. Pubmedid: 10650161.
  • Kis B, Gáspár T, Mezei Z, Gecse A, Telegdy G. Pituitary adenylate cyclase-activating polypeptide inhibits the cyclooxygenase pathway of rat cerebral microvessels. Acta Physiol Scand. 1999 Sep.167(1):43-47. Pubmedid: 10519976.
  • Kis B, Mezei Z, Dancsó G, Pataricza J, Gecse A, Papp JG, Telegdy G. Effects of pituitary adenylate cyclase-activating polypeptide on the cyclooxygenase pathway of rat platelets and on platelet aggregation. Prostaglandins Other Lipid Mediat. 1999 Oct.58(2-4):103-112. Pubmedid: 10560613.
  • Kis B, Szupera Z, Mezei Z, Gecse A, Telegdy G, Vécsei L. Valproate treatment and platelet function: the role of arachidonate metabolites. Epilepsia. 1999 Mar.40(3):307-310. Pubmedid: 10080510.
  • Kis B, Szabó CA, Pataricza J, Krizbai IA, Mezei Z, Gecse A, Telegdy G, Papp JG, Deli MA. Vasoactive substances produced by cultured rat brain endothelial cells. Eur J Pharmacol. 1999 Feb.368(1):35-42. Pubmedid: 10096767.
  • Gecse A, Kis B, Mezei Z, Telegdy G. Effects of inflammatory neuropeptides on the arachidonate cascade of platelets. Int Arch Allergy Immunol. 1999 Feb.118(2-4):166-170. Pubmedid: 10224368.
  • Kis B, Mezei Z, Gecse A, Telegdy G. The effect of substance P on the arachidonate cascade of rat platelets. Acta Physiol Hung. 1997 None.85(2):89-97. Pubmedid: 9706302.
  • Mezei Z, Kis B, Gecse A, Telegdy G, Abrahám G, Sonkodi S. Platelet eicosanoids and the effect of captopril in blood pressure regulation. Eur J Pharmacol. 1997 Dec.340(1):67-73. Pubmedid: 9527508.
  • Gecse A, Kis B, Mezei Z, Telegdy G. The effect of bradykinin and substance P on the arachidonate cascade of platelets. Immunopharmacology. 1996 Jun.33(1-3):167-170. Pubmedid: 8856141.
  • Béla K, Csongor AS, Deli MA, Ueta Y. Adrenomedullin and migraine. Headache. 42(10):1064-1065. Pubmedid: 12453043.

Patient Comments
Overall Satisfaction
0
★★★★★
★★★★★

0 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments